This rabbit polyclonal antibody recognizes human apolipoprotein A-I (ApoA1), the main protein of HDL. It recognizes whole-molecule, delipidated human ApoA-I and is supplied in liquid form in PBS with 0.05% sodium azide.
Applications include ELISA, Western blot, and immunoelectrophoresis. Purified ApoA1 and native HDL particles are also available for use as antigens or controls.
Apolipoprotein AI (Apo AI), constituting 75% of HDL-associated apolipoproteins, is critical for reverse cholesterol transport (RCT), mediating cholesterol efflux from peripheral tissues to the liver. As the primary structural component of HDL, Apo AI stabilizes discoidal HDL particles, activates lecithin-cholesterol acyltransferase (LCAT) to esterify cholesterol, and facilitates HDL maturation. Its anti-inflammatory properties include blocking T-cell–monocyte interactions, reducing TNF-α and IL-1β production, and neutralizing oxidized LDL. Apo AI concentrations are inversely correlated with coronary heart disease (CHD) risk.
Anti-Apolipoprotein AI can be utilized in assays for the quantification of human whole molecule delipidated Apo AI in biological samples. Types of assays include but are not limited to ELISAs and In Vitro Diagnostic tests.
None
None - not classified as hazardous
12 - Non Combustible Liquids
Not applicable - not a hazardous mixture. Standard laboratory hygiene practices recommended.
This rabbit polyclonal antibody recognizes human apolipoprotein A-I (ApoA1), the main protein of HDL. It recognizes whole-molecule, delipidated human ApoA-I and is supplied in liquid form in PBS with 0.05% sodium azide.
Applications include ELISA, Western blot, and immunoelectrophoresis. Purified ApoA1 and native HDL particles are also available for use as antigens or controls.